Timothy G. Whitsett - Concepedia

Author

Timothy G. Whitsett

Translational Genomics Research Institute ORCID

Also Known As

Giordano, Thomas J., Sylvia L. Asa, T. Whitsett, Timothy G Whitsett, Timothy G Whitsett Jr, Timothy G. Whitsett, Timothy G. Whitsett Jr., Timothy Whitsett, Timothy G. Whitsett, Whitsett, Timothy G

141

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Translational Genomics Research Institute St. Joseph's Hospital and Medical Center University of Maryland, Baltimore University of California San Diego The University of Texas MD Anderson Cancer Center

About

Timothy G. Whitsett is an author at Translational Genomics Research Institute specializing in medicine, pathology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.1K
2	Engineering	1	1	16
3	Health Sciences	1	1	62
4	Natural Sciences	1	1	38
5	Public Health	1	1	136

Timothy G. Whitsett

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma Siyuan Zheng, Andrew D. Cherniack, Ninad Dewal, Cancer Cell PathologyCancer GenomicsAdrenal DiseaseMedicineCancer Research	2016	645
Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. Timothy G. Whitsett, Mark Carpenter, Coral A. Lamartiniere Journal of Carcinogenesis Breast OncologyChemoprevention StrategyPathologyTumor BiologyPolyphenolics	2006	136
RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson’s disease David W. Craig, Elizabeth Hutchins, Ivo Violich, Nature Aging Neurodegenerative DiseasesAutoimmune DiseaseDisease MechanismMedicineImmunology	2021	80
Extracellular microRNAs in blood differentiate between ischaemic and haemorrhagic stroke subtypes M. Yashar S. Kalani, Eric Alsop, Bessie Meechoovet, Journal of Extracellular Vesicles	2020	70
CRL4A-FBXW5–mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth Tai Young Kim, Sarah A. Jackson, Yue Xiong, Proceedings of the National Academy of Sciences Dlc1 MrnaCrl4a-fbxw5–mediated DegradationCancer BiologyTumor BiologyTranscriptional Regulation	2013	62
Elevated Expression of Fn14 in Non-Small Cell Lung Cancer Correlates with Activated EGFR and Promotes Tumor Cell Migration and Invasion Timothy G. Whitsett, Emily H. Cheng, Landon J. Inge, American Journal Of Pathology	2012	59
WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non–Small Cell Lung Cancer Amanda L. Richer, Jacqueline M. Cala, Kelley O’Brien, Cancer Research	2017	52
A phase I/II study of TKM-080301, a <i>PLK1</i>-targeted RNAi in patients with adrenocortical cancer (ACC). Michael J. Demeure, Tannaz Armaghany, Samuel Ejadi, Journal of Clinical Oncology Phase I/ii StudyImmunologyRefractory AccPathologyInfusion Reaction	2016	49
Identification of Recurrent Activating <i>HER2</i> Mutations in Primary Canine Pulmonary Adenocarcinoma Gwendolen Lorch, Karthigayini Sivaprakasam, Victoria Zismann, Clinical Cancer Research	2019	46
Pathway Implications of Aberrant Global Methylation in Adrenocortical Cancer Christophe Legendre, Michael J. Demeure, Timothy G. Whitsett, PLoS ONE	2016	45

Page 1